A Drug Is Credited With Slight Gains for Patients Who Have Lung Cancer
Wednesday, June 4, 2008 - 11:49
in Health & Medicine
The drug Erbitux lengthened the survival of patients with advanced lung cancer by about five weeks, researchers have reported.